Treatment with difelikefalin (Korsuva) significantly reduced pruritus within 12 weeks, according to a post-hoc analysis of the KALM-1 & KALM-2 phase III trials. Pooling data on maintenance ...

Vixarelimab showed rapid, sustained itch reduction and good safety in prurigo nodularis. Learn more about the study and ...

Preliminary trial findings suggest transdermal cannabis may help ease pruritus-related itching in patients undergoing hemodialysis. Cannabis cream relieved itching symptoms over the short-term in a ...

A phase 3 trials supports the efficacy and safety of anrikefon for patients with pruritus undergoing maintenance hemodialysis. Anrikefon safely reduces pruritus itch intensity among patients receiving ...

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that the European Commission has granted marketing authorization to Kapruvia® ...

Please provide your email address to receive an email when new articles are posted on . By week 12, itch and pain scores decreased 78.3% and 53.7% in the prurigo nodular and chronic pruritus of ...

LAS VEGAS -- More options than ever exist for atopic itch conditions, offering the potential for better control but also increasing the complexity of patient management, a long-time itch research and ...

STAMFORD, Conn., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to ...

Sanofi/Regeneron, GlaxoSmithKline, Galderma/Chugai Pharmaceutical, and Mirum Pharmaceuticals, among others are progressing their assets through various clinical trial phases, driving innovation in the ...

To avoid an unnecessary call or office visit, remind patients that itching from a scabies infection may persist for as long as one to two weeks after eradication.There is usually no need for ...

Nemolizumab, which targets the interleukin-31 pathway, rapidly improves itch and sleep in people with atopic dermatitis and ...